In this regard, it has been shown recently that targeting IL-13 and IL-4 using the monoclonal antibody dupilumab resolves pruritus and inflammatory skin lesions in BP, indicating a role of neuroimmune interaction mechanisms with immune cells [29,30]. The gene discussed is IL4; the disease is Pruritus.